Monday, 13 January 2014

Bayer enters three year research partnership with Peking University

Bayer HealthCare and Peking University (PKU) have signed a collaboration agreement on a three-year strategic partnership to promote translational research for drug discovery. The two partners will establish a joint research center at Peking University under the name Bayer HealthCare/Peking University Center of Translational Research for Drug Discovery (BPC/TRDD).
According to Bayer, the collaboration will focus on applying basic research to drug discovery in the therapeutic areas of cardiology, oncology, hematology, and gynecological therapy, as well as technological research along the drug-discovery and -development value chain.
Bayer HealthCare will provide funding for collaborative research projects and sponsor a Bayer Professorship and Bayer Investigator Awards.

No comments:

Post a comment

Add a comment